<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="362137">
  <stage>Registered</stage>
  <submitdate>21/02/2012</submitdate>
  <approvaldate>24/02/2012</approvaldate>
  <actrnumber>ACTRN12612000236897</actrnumber>
  <trial_identification>
    <studytitle>Puborectalis Sling RCT - a study on reducing pelvic organ prolapse recurrences following prolapse surgery.</studytitle>
    <scientifictitle>Reducing the levator hiatus with a puborectalis sling - a multi centre randomised controlled trial for patients undergoing pelvic organ prolapse surgery</scientifictitle>
    <utrn />
    <trialacronym>N/A</trialacronym>
    <secondaryid>None</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Pelvic Organ prolapse</healthcondition>
    <conditioncode>
      <conditioncode1>Renal and Urogenital</conditioncode1>
      <conditioncode2>Other renal and urogenital disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Randomised Controlled trial - 2 arms.
One arm - patients undergoing standard pelvic organ prolapse repair surgery which may include a combination of vaginal hysterectomy, anterior +/- posterior vaginal wall repair, sacrospinous fixation +/- anti-incontinence procedures. In total, the procedure may vary from 60 minutes to 120 minutes. 
Intervention arm - patients undergoing standard pelvic organ prolapse repair ( as per above) will receive in addition, a puborectalis sling insertion, which is an additional 3x15cm strip of polypropylene mesh inserted via the obturator foramen, traversing the ischio-rectal fossa and post-anally from one side to the other. This additional mesh insertion may require an additional 15 - 30 minutes of surgical operating time.</interventions>
    <comparator>Standard or Routine pelvic organ prolapse surgical repair which may incorporate vaginal hysterectomy, anterior or posterior vaginal repair with or without mesh reinforcement. In addition, patients may also receive additional anti-incontinence surgery as necessary according to pre-operative diagnosis</comparator>
    <control>Active</control>
    <interventioncode>Treatment: surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Recurrent prolapse on transperineal ultrasound imaging
ie. Cystocele at &gt;/= 10mm below the symphysis pubis, Enterocele or cervix at &gt;/= 0mm below the symphysis pubis and Rectocele at &gt;/= 15mm below the symphysis pubis</outcome>
      <timepoint>6 weeks, 3 months, 6 months and annually thereafter for 5 years post-procedures</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Prolapse recurrence - either with symptoms of vaginal bulge or lump, Clinical prolapse recurrence ( ie &gt;/= Stage 2) on POPQ assessment</outcome>
      <timepoint>6 weeks, 3 months, 6 months and annually thereafter for 5 years post-procedure</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Ultrasound findings of levator hiatal area</outcome>
      <timepoint>6 weeks, 3 months, 6 months and annually thereafter for 5 years post-procedure</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Questionnaire scores - (ICIQ-VS, PFDI) to assess for prolapse symptoms and its association with urinary and bowel function</outcome>
      <timepoint>6 weeks, 3 months, 6 months and annually thereafter for 5 years post-procedure</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Questionnaire scores - (PIQ-6) to assess for pain and it's impact on quality of life</outcome>
      <timepoint>6 weeks, 3 months, 6 months and annually thereafter for 5 years post-procedure</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Questionnaire scores - (PSIQ-12) to assess for sexual function</outcome>
      <timepoint>6 weeks, 3 months, 6 months and annually thereafter for 5 years post-procedure</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>All patients undergoing conventional/standard pelvic organ prolapse surgery with an enlarged levator hiatus (&gt;30cm2) and have completed family</inclusivecriteria>
    <inclusiveminage>30</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Overt neuromuscular abnormality, Levator hiatus of &lt;30cm2, Inability to attend follow-up or comply with study protocol or inability to give informed consent and patients who are still intending on future pregnancies</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Patients will be recruited directly by participating surgeons. Randomisation will occur just prior to surgery, with a central office co-ordinating block randomisation with sealed envelopes.</concealment>
    <sequence>Permuted block randomisation</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/03/2012</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>200</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <postcode>2750</postcode>
    <postcode>2050</postcode>
    <postcode>2217</postcode>
    <postcode>4810</postcode>
    <postcode>3144</postcode>
    <postcode>4120</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of Sydney</primarysponsorname>
    <primarysponsoraddress>Nepean Hospital
Derby Street, Penrith
NSW 2750</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>RANZCOG</fundingname>
      <fundingaddress>254 - 260 Albert St
East Melbourne
Victoria
3002</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Prof Kate Moore</othercollaboratorname>
      <othercollaboratoraddress>St George Hospital
Belgrave Street, Kogarah
NSW 2217</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Prof Andrew Korda</othercollaboratorname>
      <othercollaboratoraddress>Royal Prince Alfred Hospital
Missenden Road, Camperdown
NSW 2050</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Prof Ajay Rane</othercollaboratorname>
      <othercollaboratoraddress>Townsville Hospital
POBOX 1417
Thuringowa Central, Townsville
Queensland 4817</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Prof Anna Rosamilia</othercollaboratorname>
      <othercollaboratoraddress>Monash Medical Centre
Suite 8, Cabrini Medical Centre
183 Wattletree Road
Melbourne, Victoria 3144</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Prof Judith Goh</othercollaboratorname>
      <othercollaboratoraddress>Suite 209
Ramsay Specialist Centre
Greenslopes Private Hospital
Greenslopes, Queensland 4120</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study aims to determine if a new technique in treating prolapse will give a better long term result than the current standard treatment. The new technique aims to reduce the size of the opening in the pelvic floor and is done at the same time as the standard prolapse repair surgery.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Nepean  Blue Mountains LHD HREC</ethicname>
      <ethicaddress>Court Building, Ground Floor
PO BOX 63
Penrith, NSW 2751</ethicaddress>
      <ethicapprovaldate>29/09/2011</ethicapprovaldate>
      <hrec>HREC/11/NEPEAN/54</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Prof Hans Peter Dietz</name>
      <address>Nepean Hospital
Level 5, Spurrett Bldg
Derby Street
Penrith, NSW 2750</address>
      <phone>(+61)247341474</phone>
      <fax>(+61)247341817</fax>
      <email>hpdietz@med.usyd.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Prof Hans Peter Dietz</name>
      <address>Nepean Hospital
Level 5, Spurrett Bldg
Derby Street
Penrith, NSW 2750</address>
      <phone>(+61)247341474</phone>
      <fax>(+61)247341817</fax>
      <email>hpdietz@med.usyd.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Prof Hans Peter Dietz</name>
      <address>Nepean Hospital
Level 5, Spurrett Bldg
Derby Street
Penrith, NSW 2750</address>
      <phone>(+61)247341474</phone>
      <fax>(+61)247341817</fax>
      <email>hpdietz@med.usyd.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>